이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

The Effect of a Structured Workplace Exercise Program on 360-Degree Performance Evaluation, Job Motivation, Productivity, and Quality of Work Life (PADRA-EXER)

2026년 9월 11일 업데이트: Zinat Ebrahimi, Islamic Azad University, Sanandaj

The Effect of a 12-Week Structured Workplace Exercise Program on AGIO Productivity, 360-Degree Performance Evaluation, Herzberg Job Motivation, and Walton Quality of Work Life: A Quasi-Experimental Pre-Test/Post-Test Study in a Medical Garment Manufacturing Factory

This quasi-experimental, single-group pre-test/post-test study is designed to evaluate the effects of a 12-week structured workplace exercise program on four human capital indicators among employees of a medical garment manufacturing factory in Sanandaj, Kurdistan Province, Iran. The study population consists of 150 employees working in production, cutting, quality control, technical maintenance, and administrative departments. Following clinical screening by an occupational medicine specialist and completion of the PAR-Q questionnaire, eligible participants will be enrolled. The exercise intervention consists of 24 sessions (2 sessions per week, 60 minutes each) delivered by a certified fitness instructor. Outcome measures include AGIO human resource productivity, 360-degree performance evaluation, Herzberg job motivation, and Walton quality of work life, assessed at baseline and post-intervention. This study has been approved by the Research Ethics Committee of Islamic Azad University, Sanandaj Branch (IR.IAU.SANANDAJ.REC.1405.152).

연구 개요

상세 설명

This study employs a quasi-experimental, single-group pre-test/post-test design with a mixed-methods (quantitative-qualitative) approach. The study is conducted at a medical protective apparel and healthcare sanitary wear manufacturing plant in Sanandaj, Kurdistan Province, Iran. Workers primarily perform sedentary-to-light manual tasks including fabric cutting, sewing, quality inspection, and packaging under a two-shift rotation system. The study period runs from April to July 2025 (1 Ordibehesht to 24 Tir 1404, Iranian calendar). Baseline (T1) assessments are completed one week before session 1; post-intervention (T2) assessments are completed within one week of session 24. The study protocol was approved by the Research Ethics Committee of Islamic Azad University, Sanandaj Branch (Ethics Code: IR.IAU.SANANDAJ.REC.1405.152). Written informed consent is obtained from all participants before enrolment.

Participants: All 150 employees of the facility are invited for eligibility screening. A licensed occupational medicine physician conducts clinical examinations supplemented by the Physical Activity Readiness Questionnaire (PAR-Q). Employees with uncontrolled cardiovascular disease, severe respiratory disorders, musculoskeletal conditions incompatible with moderate-intensity exercise, pregnancy, or other physician-identified contraindications are excluded. Eligible employees who provide written informed consent are enrolled. Sample size adequacy is confirmed using Cochran's formula for finite populations (N = 150; 95% CI; margin of error = 0.05; p = q = 0.50), and statistical power is verified using G*Power 3.1.

Intervention Protocol: The 12-week structured exercise program comprises 24 sessions (2 × 60 min/week), delivered by a fitness instructor holding a Grade-2 certification from the Physical Fitness Federation of the Islamic Republic of Iran. Sessions are consistently held at 10:00 AM before shift handovers. The facility's dedicated sports hall provides a climate-controlled environment (25-26°C; 60% relative humidity) consistent with ACSM guidelines for moderate-intensity aerobic exercise. Each session includes a 10-minute warm-up with joint mobility and dynamic stretching, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional core exercises, calisthenics, and cooperative small-sided games, and a 10-minute cool-down with static stretching, spinal elongation, and guided diaphragmatic breathing. Aerobic intensity is targeted at 60-75% of heart rate reserve using the Karvonen formula, monitored via the Borg Rating of Perceived Exertion (RPE; 6-20 scale; target 12-14). All phases are instructor-led; no self-directed activities are included.

Outcome Measures: Four validated instruments are administered at baseline (T1) and post-intervention (T2). (1) The 40-item Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015) assesses two independent subscales: Intrinsic/Motivator factors (20 items) and Extrinsic/Hygiene factors (20 items), using a 5-point Likert scale. (2) The 26-item AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980; validated by Mehri, 2013) assesses seven subscales: Ability, Role Clarity, Organizational Support, Motivation, Feedback, Credibility, and Environmental Fit, using a 5-point Likert scale. (3) A 360-degree performance evaluation questionnaire (Poursoltani et al., 2010) collects ratings from four sources: supervisor, peer, subordinate, and self. (4) The Walton Quality of Work Life Questionnaire (Walton, 1973; Iranian validation by Rahimi, 2005) assesses eight dimensions including fair compensation, safe working conditions, and growth opportunities.

Statistical Analysis Plan: All analyses will use IBM SPSS Statistics v26.0. Composite scale scores (≥ 10 items) will be treated as continuous interval-level data for parametric analyses. Shapiro-Wilk tests will verify univariate normality. For the primary pre-post comparisons, paired-samples t-tests will be used with a Bonferroni-adjusted significance threshold. For the cross-sectional association between post-intervention motivation, 360-degree appraisal, and productivity, an enter-method multiple linear regression will be used. A supplementary regression will include T1 motivation as a covariate. Model assumptions will be verified (VIF < 2.0 for multicollinearity; Durbin-Watson for autocorrelation). One-way ANOVA with partial eta-squared will examine whether demographic characteristics moderate post-intervention outcomes. Qualitative interview data from 10 semi-structured interviews will undergo thematic content analysis (open, axial, and selective coding) as a planned exploratory component of the study.

연구 유형

중재적

등록 (실제)

109

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Kurdistan Province
      • Sanandaj, Kurdistan Province, 이란, 6616947455
        • PADRA Medical Garment Manufacturing Factory

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인

건강한 자원 봉사자를 받아들입니다

예

설명

Inclusion Criteria:

  1. Employment at PADRA Medical Garment Manufacturing Factory
  2. Age between 20 and 60 years
  3. Successful completion of clinical examination by an occupational medicine specialist
  4. Successful completion of the PAR-Q (Physical Activity Readiness Questionnaire) with no contraindications
  5. Voluntary written informed consent to participate in the study
  6. Willingness to attend 2 exercise sessions per week for 12 weeks

Exclusion Criteria:

  1. Uncontrolled cardiovascular diseases (e.g., uncontrolled hypertension, recent myocardial infarction)
  2. Severe respiratory disorders (e.g., severe asthma, COPD)
  3. Musculoskeletal problems that contraindicate moderate-intensity physical activity
  4. Any medical contraindication for moderate-intensity exercise as determined by occupational medicine specialist
  5. Pregnancy
  6. Withdrawal of informed consent at any stage of the study
  7. Failure to complete pre-test or post-test questionnaires

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Workplace Exercise Intervention Group
Participants received a 12-week structured workplace exercise program consisting of 24 sessions (60 minutes each, 2 sessions per week). Each session included a 10-minute warm-up with dynamic movements and joint mobilization, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional endurance training and team-based games (volleyball, small-sided football, passing drills), and a 10-minute cool-down with static stretching, relaxation, and guided diaphragmatic breathing. Exercise intensity was monitored using the Borg Rating of Perceived Exertion (RPE) scale with a target range of 12-14. The intervention was conducted at the factory's adjacent sports hall at 10:00 AM, with ambient temperature maintained at 25-26°C. Attendance was high: 107 out of 109 participants completed ≥22 of 24 sessions. No adverse events or protocol deviations were recorded. Outcomes measured pre- and post-intervention included AGIO productivity, 360-degree perfor
A 12-week structured exercise program consisting of 24 sessions (60 minutes each, 2 sessions per week). Each session includes a 10-minute warm-up with dynamic movements and joint mobilization, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional endurance training and team-based games (volleyball, small-sided football, passing drills), and a 10-minute cool-down with static stretching, relaxation, and guided diaphragmatic breathing. Intensity monitored by Borg RPE scale (target 12-14). Conducted at factory sports hall, 10:00 AM, 25-26°C. No adverse events recorded.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
AGIO Productivity Score
기간: Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980) with 7 subscales: ability, role clarity, organizational support, motivation, feedback, credibility, and environmental adaptability. Scores range from 1 to 5, with higher scores indicating greater productivity.
Baseline (Week 0) and Post-Intervention (Week 12)
360-Degree Performance Evaluation Score
기간: Baseline (Week 0) and Post-Intervention (Week 12)
Description: Measured using the 360-Degree Performance Evaluation Questionnaire (Poursoltani et al., 2010) with 4 sources: supervisor, peer, subordinate, and self. Scores range from 1 to 5, with higher scores indicating better performance.
Baseline (Week 0) and Post-Intervention (Week 12)
Herzberg Job Motivation Score
기간: Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015) assessing intrinsic (motivational) and extrinsic (hygiene) factors. Scores range from 1 to 5, with higher scores indicating greater job motivation.
Baseline (Week 0) and Post-Intervention (Week 12)
Walton Quality of Work Life Score
기간: Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the Walton Quality of Work Life Questionnaire (Walton, 1973; Iranian validation by Rahimi, 2005) with 8 dimensions including fair compensation, safe working conditions, and growth opportunities. Scores range from 1 to 5, with higher scores indicating better quality of work life.
Baseline (Week 0) and Post-Intervention (Week 12)

2차 결과 측정

결과 측정
측정값 설명
기간
AGIO Subscale Scores
기간: Baseline (Week 0) and Post-Intervention (Week 12)
Individual subscale scores of the AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980) including Ability, Role Clarity, Organizational Support, Motivation, Feedback, Credibility, and Environmental Fit. Each subscale score ranges from 1 to 5, with higher scores indicating greater productivity.
Baseline (Week 0) and Post-Intervention (Week 12)
Herzberg Factor Scores
기간: Baseline (Week 0) and Post-Intervention (Week 12)
Separate scores for the Intrinsic/Motivator factors and Extrinsic/Hygiene factors of the Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015). Each factor score ranges from 1 to 5, with higher scores indicating greater job motivation.
Baseline (Week 0) and Post-Intervention (Week 12)

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2002년 4월 21일

기본 완료 (실제)

2025년 7월 15일

연구 완료 (실제)

2025년 7월 15일

연구 등록 날짜

최초 제출

2026년 9월 7일

QC 기준을 충족하는 최초 제출

2026년 9월 11일

처음 게시됨 (실제)

2026년 9월 17일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 11일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다